Protests against Monsanto rise after the company has been commissioned to compensate American with cancer – Times Business

RoundUp herbicide is one of Monsanto's glyphosate-containing products (Photo: GETTY IMAGES via BBC News Brazil)

the Monsanto, a manufacturer of chemicals, has seen the number of lawsuits against her since she was sentenced earlier this month to pay compensation to a man with terminal cancer.

In the United States, the number of shares rose from 5.2 thousand to 8,000 after the American court sentenced the company to pay $ 289,000 ($ 1.1 billion) to Californian gardener Dewayne Johnson, who said that his illness was caused by the pesticides Roundup and RangerPro.

learn more

After a trial period of eight weeks, jurors decided on 10 August that the company was "malicious" and that the herbicides "substantially" contributed to Johnson's disease.

The company denied that its products are carcinogenic and said it will be appreciated.

The lawsuits could generate billions of dollars in losses for Bayer, which recently bought Monsanto, because the conviction has set a precedent for similar decisions. Bayer shares have lost 11% of their value since the court's decision came to the public.

German company chairman Werner Baumann said that Bayer "could not predict the current number of procedures" when it bought Monsanto. The executive also said that the company is of the opinion that "the number of cases is not indicative of the merits of the requests (ie the probability that a decision is in conflict with the company)."

The case of the Californian gardener was the first to claim that pesticides with glyphosate cause cancer to appear in court.

The substance creates controversy. The American Environmental Regulatory Agency authorizes its use in the country. The World Health Organization (WHO), however, classified glyphosate in 2015 as "probably carcinogenic to humans."

Company denies that the product causes cancer
The president of Bayer repeated Thursday what the company had already said about glyphosate, and denied that the product is carcinogenic and says it appeals against the decision.

In a statement issued after the verdict, Monsanto says it empathizes with Johnson and his family, but will continue to vigorously defend his product, which has a record of 40 years. safe use & # 39 ;.

Liam Condon, head of Bayer's Harvest Science division, said: "There has been no change in the regulatory status of the product. There is a huge demand, for decades, for glyphosate.

Signature BBC footer (photo: BBC)

Source link

Leave a Reply